[Evidence summary:] How safe and effective are COVID 19 vaccines in adolescents, and what is the uptake of COVID 19 vaccines in adolescents? [v1.0]
dc.contributor.author | White, Gethin | |
dc.contributor.author | Morgan, Margaret | |
dc.contributor.author | Barrett, Shauna | |
dc.contributor.author | McCarthy, Siobhán | |
dc.contributor.author | Leen, Brendan | |
dc.contributor.author | NIAC Subgroup | |
dc.date.accessioned | 2021-09-13T11:27:07Z | |
dc.date.available | 2021-09-13T11:27:07Z | |
dc.date.issued | 2021-09-13 | |
dc.identifier.uri | http://hdl.handle.net/10147/630368 | |
dc.description | Main Points 1. Authorization of the Pfizer BioNTech COVID 19 vaccine for adolescents is based on an ongoin g cli nical trial that reports 100% vaccine efficacy against SARS CoV 2 infection from 7 days after the second dose , and immunogenicity and adverse effect profiles comparable to those in the adult population. No vaccine related severe adverse events have been observed 2. Cases of myocarditis and pericarditis following mRNA vaccination in children and adolescents are rare and typically resolve rapidly 3. Based on cross sectional studies in Canada, Israel and Italy, intention to vaccinate children and adolescents against COVID 19 is high (~ 90 Obtaining reliable information about adolescent COVID 19 vaccine safety a nd efficacy , and having parents or guardians who have been vaccinated are among the factors that inc rease vaccination intent among both parents and adolescents. Parents inc lined not to vaccinate indicate short development time and possible long term effect s as dissuading factors. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.relation.ispartofseries | Q.214 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | VACCINATION | en_US |
dc.subject | IMMUNISATION | en_US |
dc.subject | ADOLESCENTS | en_US |
dc.title | [Evidence summary:] How safe and effective are COVID 19 vaccines in adolescents, and what is the uptake of COVID 19 vaccines in adolescents? [v1.0] | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2021-09-13T11:27:08Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics